Anavex Life Sciences Corp (AVXL): Next-Year EPS Estimate 56.43%
As of 2026-05-28, Anavex Life Sciences Corp (AVXL) has a next-year EPS growth estimate of 56.43%.
On 2026-03-27, analyst consensus for AVXL's next-year EPS growth shifted from 56.92% to 56.43% — a negative change of 0.49 percentage points. The revised estimate has been sustained across 57 subsequent trading sessions. Current-year growth is projected at 39.52%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 56.43%
- EPS growth this year
- 39.52%
- EPS next quarter (est)
- -$0.07
- Last price
- $2.94
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-05-28 | 56.43% | 39.52% | -$0.07 | $2.94 |
| 2026-05-27 | 56.43% | 39.52% | -$0.07 | $2.76 |
| 2026-05-26 | 56.43% | 39.52% | -$0.07 | $2.71 |
| 2026-05-25 | 56.43% | 39.52% | -$0.07 | $2.69 |
| 2026-05-24 | 56.43% | 39.52% | -$0.07 | $2.69 |
| 2026-05-21 | 56.43% | 39.52% | -$0.07 | $2.71 |
| 2026-05-20 | 56.43% | 39.52% | -$0.07 | $2.75 |
| 2026-05-19 | 56.43% | 39.52% | -$0.07 | $2.67 |
| 2026-05-18 | 56.43% | 39.52% | -$0.07 | $2.88 |
| 2026-05-17 | 56.43% | 39.52% | -$0.07 | $2.91 |
| 2026-05-14 | 56.43% | 39.52% | -$0.07 | $3.08 |
| 2026-05-13 | 56.43% | 39.52% | -$0.07 | $3.03 |
| 2026-05-12 | 56.43% | 39.52% | -$0.07 | $3.06 |
| 2026-05-11 | 56.43% | 39.52% | -$0.07 | $3.24 |
| 2026-05-10 | 56.43% | 39.52% | -$0.07 | $3.22 |
| 2026-05-07 | 56.43% | 39.52% | -$0.07 | $3.12 |
| 2026-05-06 | 56.43% | 39.52% | -$0.07 | $3.34 |
| 2026-05-05 | 56.43% | 39.52% | -$0.07 | $3.36 |
| 2026-05-04 | 56.43% | 39.52% | -$0.07 | $3.41 |
| 2026-05-03 | 56.43% | 39.52% | -$0.07 | $3.32 |
| 2026-04-30 | 56.43% | 39.52% | -$0.07 | $3.34 |
| 2026-04-29 | 56.43% | 39.52% | -$0.07 | $3.26 |
| 2026-04-28 | 56.43% | 39.52% | -$0.07 | $3.37 |
| 2026-04-27 | 56.43% | 39.52% | -$0.07 | $3.29 |
| 2026-04-26 | 56.43% | 39.52% | -$0.07 | $3.34 |
| 2026-04-24 | 56.43% | 39.52% | -$0.07 | $3.34 |
| 2026-04-23 | 56.43% | 39.52% | -$0.07 | $3.31 |
| 2026-04-22 | 56.43% | 39.52% | -$0.07 | $3.61 |
| 2026-04-21 | 56.43% | 39.52% | -$0.07 | $3.50 |
| 2026-04-20 | 56.43% | 39.52% | -$0.07 | $3.65 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Anavex Life Sciences Corp's next-year EPS growth estimate?▾
As of 2026-05-28, Anavex Life Sciences Corp (AVXL) has a next-year EPS growth estimate of 56.43%, based on analyst consensus.
When was the latest EPS estimate revision for AVXL?▾
The most recent revision occurred on 2026-03-27, when analysts adjusted the next-year EPS growth estimate from 56.92% to 56.43%.
What sector and industry does Anavex Life Sciences Corp belong to?▾
Anavex Life Sciences Corp operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. AVXL appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Anavex Life Sciences Corp (AVXL) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports